| P50 | author | Ralph W. Kupka | Q91605544 |
| | Willem A Nolen | Q92189033 |
| | Trisha Suppes | Q97540231 |
| | Gabriele S. Leverich | Q111732463 |
| | Paul E. Keck | Q111738411 |
| | Kirk D Denicoff | Q114420727 |
| | Lori L. Altshuler | Q22003115 |
| | Susan L McElroy | Q56816544 |
| | David C. Black | Q78078621 |
| | Robert M. Post | Q87613308 |
| | Gerhard Hellemann | Q88498656 |
| | Mark A Frye | Q90298035 |
| P2093 | author name string | Jim Mintz | |
| P2860 | cites work | Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up | Q28182929 |
| | Topiramate titration and tolerability | Q32052884 |
| | The efficacy and safety of sibutramine for weight loss: a systematic review | Q33202786 |
| | Excess mortality in bipolar and unipolar disorder in Sweden | Q33954560 |
| | Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial | Q33964132 |
| | Meta-analysis: pharmacologic treatment of obesity | Q34408897 |
| | Open-label adjunctive topiramate in the treatment of bipolar disorders. | Q34509360 |
| | Clinical outcome of adjunctive topiramate treatment in a sample of refractory bipolar patients with comorbid conditions | Q35009401 |
| | Changes in body weight and body mass index among psychiatric patients receiving lithium, valproate, or topiramate: an open-label, nonrandomized chart review | Q35014566 |
| | Behavioural effects of the newer antiepileptic drugs: an update | Q35609738 |
| | How can drug addiction help us understand obesity? | Q36108706 |
| | Comorbidity of bipolar and eating disorders: distinct or related disorders with shared dysregulations? | Q36151125 |
| | The Stanley Foundation Bipolar Treatment Outcome Network. I. Longitudinal methodology. | Q40656925 |
| | Effects of eating behavior on mood: a review of the literature | Q40860503 |
| | Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials | Q42164457 |
| | Prevalence of obesity and weight change during treatment in patients with bipolar I disorder | Q43642752 |
| | Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study | Q44103185 |
| | Obesity as a correlate of outcome in patients with bipolar I disorder | Q44265285 |
| | A Randomized, Double-blind, Placebo-Controlled Study of Sibutramine in the Treatment of Binge-Eating Disorder | Q44650361 |
| | Exposure to appetitive food stimuli markedly activates the human brain | Q44819138 |
| | Effects on weight and outcome of long-term olanzapine-topiramate combination treatment in bipolar disorder. | Q44962387 |
| | Hypomania with topiramate | Q45288129 |
| | A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain. | Q46465959 |
| | A pilot controlled trial of topiramate for mania in children and adolescents with bipolar disorder | Q46503060 |
| | Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians | Q46714706 |
| | Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers | Q46921505 |
| | The pharmacology of sibutramine hydrochloride (BTS 54 524), a new antidepressant which induces rapid noradrenergic down-regulation | Q48163276 |
| | Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology | Q48575894 |
| | A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects | Q56774146 |
| P433 | issue | 4 | |
| P921 | main subject | obesity | Q12174 |
| | (RS)-sibutramine | Q424151 |
| | weight gain | Q3403879 |
| P304 | page(s) | 426-434 | |
| P577 | publication date | 2007-06-01 | |
| P1433 | published in | Bipolar Disorders | Q15716681 |
| P1476 | title | A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders | |
| P478 | volume | 9 | |